Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid × Gemtuzumab × Clear all

NCT00233909 2008-04-01

A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Recurrence